Status:
COMPLETED
Feasibility of Monitoring Cancer Patients With a Smart T-shirt: Protocol for the OncoSmartShirt Study
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will assess the feasibility of using the ChronolifeTM smart t-shirt for home monitoring of vital parameters in cancer patients during their treatment course. This study will bring new insigh...
Detailed Description
Collecting biometric sensor data by wearables is an example of real-time patient-generated health data that can provide vital and detailed objective information about patients. This may have the poten...
Eligibility Criteria
Inclusion
- Danish cancer patients ≥18 years in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark
- Both patients in curative and palliative care will be eligible
- 10 cancer patients under 39 years
- 10 cancer patients over 65 years
- Able to read and speak Danish
Exclusion
- Serious cognitive deficits
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05235594
Start Date
March 1 2022
End Date
October 1 2022
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 3450